Skip to main content
Midas Edge

ORAMED PHARMACEUTICALS INC.

For the period ended Aug 19, 2025. Filed Jul 16, 2025.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Aug 19, 2025 · Filed Jul 16, 2025

Use the contents to explore the available documents and sections.

ORMP$3.86-0.8%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Code of Ethics

We have adopted a Code of Ethics and Business Conduct for our senior officers, directors and employees. A copy of the Code of Ethics and Business Conduct is located at our website atwww.oramed.com. We intend to satisfy the disclosure requirement regarding any amendment to, or a waiver from, a provision of the Code of Ethics that applies to our Chief Executive Officer, Chief Financial Officer or controller, or persons performing similar functions and that relates to the Code of Ethics by posting such information on our website, www.oramed.com.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.